Compugen Ltd.
CGEN
$1.65
$0.042.48%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
3/7/2025
-
MarketBeat
3/6/2025
-
Ticker Report
3/5/2025
-
Insider Monkey
3/5/2025
-
Simply Wall St
3/5/2025
-
GuruFocus
3/5/2025
-
GuruFocus
3/4/2025
-
SeekingAlpha
3/4/2025
-
Seeking Alpha: Transcripts
3/4/2025
-
Seeking Alpha - Israel Stocks
3/4/2025
-
GuruFocus
3/4/2025
-
Ticker Report
3/4/2025
-
MarketBeat
3/4/2025
-
Zacks Investment Research
3/4/2025
-
GuruFocus
3/4/2025
-
TipRanks Financial Blog
3/4/2025
-
The Fly
3/4/2025
-
PR Newswire
Compugen to Participate in a Fireside Chat at the 2025 Leerink Partners Global Healthcare Conference
3/3/2025
-
GuruFocus
Compugen to Participate in a Fireside Chat at the 2025 Leerink Partners Global Healthcare Conference
3/3/2025
-
PR Newswire
2/26/2025
-
Simply Wall St
2/26/2025
-
PR Newswire
2/25/2025
-
MarketBeat
2/18/2025
-
GuruFocus
2/18/2025
-
PR Newswire
2/18/2025
-
SeekingAlpha
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Tuesday, March 4, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 19 and 23 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
972 3 765 8585
Address
Azrieli Center
Building D - 26 Harokmim Street
Holon, 5885849
Building D - 26 Harokmim Street
Holon, 5885849
Country
Year Founded
Business Description
Sector
Compugen Ltd., a clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutics and product candidates in Israel, the...
more
